Clinical Trials Browser

OTHER × Lymphoma, Follicular × pixantrone × Clear all

NCT02499003 2022-03-31

GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma

Phase 2 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse